SCHEMBL13759482

SCHEMBL13759482

c1cc(-c2ccc3ccccc3c2)cc(-c2c3ccccc3c(-c3ccc(-c4cnc5ccccc5c4)nc3)c3ccccc23)c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BIRC5 O15392 1/20 0.48
PIK3CD O00329 2/20 0.44
PIK3CA P42336 2/20 0.44
PIK3CB P42338 1/20 0.44
MTOR P42345 1/20 0.44
PIK3CG P48736 1/20 0.44
MAP4K4 O95819 1/20 0.43
CSNK1G2 P78368 1/20 0.43
CLK4 Q9HAZ1 1/20 0.43
MKNK2 Q9HBH9 1/20 0.43
MAP4K5 Q9Y4K4 1/20 0.43
CYP2A6 P11509 1/20 0.43
PDGFRB P09619 3/20 0.41
PDGFRA P16234 3/20 0.41
TOP2A P11388 1/20 0.40
TOP2B Q02880 1/20 0.40
CA12 O43570 1/20 0.39
CA1 P00915 1/20 0.39
CA2 P00918 1/20 0.39
CA9 Q16790 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13759495 0.97 BIRC5 (0.48) BIRC5PIK3CDPIK3CAPIK3CBMTOR
SCHEMBL13759478 0.95 PDGFRB (0.45) BIRC5PIK3CDPIK3CAPIK3CBMTOR
SCHEMBL13759476 0.91 PIK3CD (0.47) BIRC5PIK3CDPIK3CAPIK3CBMTOR
SCHEMBL2601568 0.90 PIK3CA (0.44) BIRC5PIK3CDPIK3CAPIK3CBMTOR
SCHEMBL13759489 0.90 PDGFRB (0.47) BIRC5PIK3CDPIK3CAPIK3CBMTOR
SCHEMBL28223699 0.89 HSD17B1 (0.44) CYP17A1CYP19A1CYP11B1CYP11B2HSD17B1
SCHEMBL13759448 0.89 PDGFRB (0.43) BIRC5PIK3CDPIK3CAPIK3CBMTOR
SCHEMBL12436195 0.88 HSD17B1 (0.44) CYP17A1CYP19A1CYP11B1CYP11B2HSD17B1
SCHEMBL19374105 0.88 PIK3CA (0.43) BIRC5PIK3CDPIK3CAPIK3CBMTOR
SCHEMBL17246773 0.88 PIK3CA (0.43) BIRC5PIK3CDPIK3CAPIK3CBMTOR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210359214-A1 ORGANIC LIGHT-EMITTING DEVICE AND APPARATUS INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2021-11-18 US disclosed
US-8367219-B2 Anthracene-based compound and organic light emitting device employing the same SAMSUNG ELECTRONICS CO., LTD. (KR) 2013-02-05 US disclosed
US-8367220-B2 Anthracene-based compound and organic light emitting device employing the same SAMSUNG ELECTRONICS CO., LTD. (KR) 2013-02-05 US disclosed
US-8367219-B2 Anthracene-based compound and organic light emitting device employing the same SAMSUNG ELECTRONICS CO., LTD. (KR) 2013-02-05 US disclosed
US-8367220-B2 Anthracene-based compound and organic light emitting device employing the same SAMSUNG ELECTRONICS CO., LTD. (KR) 2013-02-05 US disclosed
US-20090166670-A1 Anthracene-based compound and organic light emitting device employing the same SAMSUNG DISPLAY CO., LTD. (KR) 2009-07-02 US disclosed
US-20090166670-A1 Anthracene-based compound and organic light emitting device employing the same SAMSUNG DISPLAY CO., LTD. (KR) 2009-07-02 US disclosed
EP-2055702-A1 Anthracene-based compound and organic light emitting device employing the same Samsung Electronics Co., Ltd. (KR) 2009-05-06 EP disclosed
US-20090108746-A1 Anthracene-based compound and organic light emitting device employing the same SAMSUNG DISPLAY CO., LTD. (KR) 2009-04-30 US disclosed
US-20090108746-A1 Anthracene-based compound and organic light emitting device employing the same SAMSUNG DISPLAY CO., LTD. (KR) 2009-04-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090166670-A1 Anthracene-based compound and organic light emitting device employing the same CCNL2, CRY2, ATXN2L BIRC5 283/4885PIK3CD 3696/4885PIK3CA 3309/4885
US-20090108746-A1 Anthracene-based compound and organic light emitting device employing the same CCNL2, CRY2, ATXN2L BIRC5 283/4885PIK3CD 3696/4885PIK3CA 3309/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.